The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

The FDR outcome directs FDA divisions to finalize labeling with the sponsor, reversing the prior CRL trajectory and ...

Individuals in Taiwan who suffer from migraine were at an increased risk of developing neovascular age-related macular degeneration. Individuals suffering from migraine have a 20% increased risk of ...

Please provide your email address to receive an email when new articles are posted on . Sozinibercept, a VEGF-C and -D “trap” inhibitor, showed improved durability in patients with retinal diseases ...

In patients with a diagnosis of early- or intermediate-stage nonneovascular age-related macular degeneration (AMD), exposure to levodopa was associated with a significantly reduced risk for conversion ...

—The findings about the diagnostic accuracy of the Amsler grid test for early detection of neovascular age-related macular degeneration suggest that the procedure will not replace regular ophthalmic ...

(RTTNews) - The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Vabysmo or faricimab for the ...

In patients with neovascular age-related macular degeneration (nAMD), researchers found no clinically meaningful difference between treatment with the anti-VEGF agent aflibercept and the proposed ...

Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from ...

Please provide your email address to receive an email when new articles are posted on . Central retinal thickness and macular volume increased at 2 months postop but returned to preop levels at 6 ...